References

No references inside the corpus for this window.

Cited by

• 2021Global COVID-19 vaccine inequity: The scope, the impact, and the challenges170 cited
• 2021COVAX and the rise of the ‘super public private partnership’ for global health156 cited
• 2021COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions155 cited
• 2022COVAX, vaccine donations and the politics of global vaccine inequity141 cited
• 2021Disparities in COVID-19 Vaccination among Low-, Middle-, and High-Income Countries: The Mediating Role of Vaccination Policy82 cited
• 2021Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries81 cited
• 2022A systematic review of pooled procurement of medicines and vaccines: identifying elements of success80 cited
• 2022Barriers to COVID-19 Health Products in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Rapid Systematic Review and Evidence Synthesis79 cited
• 2021Vaccine nationalism: contested relationships between COVID-19 and globalization74 cited
• 2023The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making68 cited
• 2023Global inequities in access to COVID-19 health products and technologies: A political economy analysis62 cited
• 2023Causes and costs of global COVID-19 vaccine inequity55 cited